Metabolic bone disease in IBD.
A substantial number of patients with inflammatory bowel disease (IBD) will manifest extra-intestinal complications. Metabolic bone disease and arthropathies are among the most debilitating of these. Decreased bone mineral density and increased fracture risk may occur in relation to the underlying disease itself or result from vitamin, mineral, and hormonal deficiencies; medications used to treat the underlying disease; lifestyle; and perhaps other factors. In many cases, the factors remain unidentified. Options for the treating clinician include correction of these deficiencies, treatment of the underlying disease, and use of medication to promote bone formation and decrease bone resorption.
Lopez
I
I
Division of Gastroenterology, Hepatology and Nutrition, University of Texas-Houston Medical School, Houston, TX, USA.
Buchman
A L
AL
D001168:Arthritis / Q000175:diagnosis / Q000209:etiology; D015519:Bone Density; D001851:Bone Diseases, Metabolic / Q000209:etiology* / Q000503:physiopathology; D002136:Calcium, Dietary / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000503:physiopathology; D007413:Intestinal Mucosa / Q000378:metabolism; D008286:Malabsorption Syndromes / Q000150:complications; D010018:Osteomalacia / Q000209:etiology; D010024:Osteoporosis / Q000209:etiology / Q000517:prevention & control; D014813:Vitamin K Deficiency / Q000209:etiology
D002136:Calcium, Dietary; D016207:Cytokines